Interferon therapy for chronic type B hepatitis: the promise comes of age.

[1]  J. Hoofnagle,et al.  Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters. , 1990, American Journal of Gastroenterology.

[2]  P. Hofschneider,et al.  β- and γ-Interferon in Chronic Active Hepatitis B: A Pilot Trial of Short-Term Combination Therapy , 1989 .

[3]  J. Hoofnagle,et al.  Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B , 1988 .

[4]  M. Peters,et al.  Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. , 1988, Annals of internal medicine.

[5]  R. Perrillo Antiviral theraphy of chronic viral hepatitis , 1988 .

[6]  M. Rugge,et al.  Chronic hepatitis in childhood: the spectrum of the disease. , 1988, Gut.

[7]  G. Garcia,et al.  Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial. , 1987, Annals of internal medicine.

[8]  Heather M. Smith,et al.  Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection , 1993, Journal of medical virology.

[9]  J. Harris,et al.  Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV‐III antibodies to recombinant α‐interferon , 1987, Hepatology.

[10]  J. Hoofnagle,et al.  Randomized Controlled Trial of a Four Month Course of Recombinant Human Alpha Interferon in Patients with Chronic Type B Hepatitis , 1987 .

[11]  P. Karayiannis,et al.  Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment. , 1987, Journal of hepatology.

[12]  J. Hoofnagle,et al.  Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis. , 1986, Journal of immunology.

[13]  J. Hoofnagle,et al.  Interferon in viral hepatitis: Role in pathogenesis and treatment , 1986, Hepatology.

[14]  J. Hoofnagle,et al.  The interferon system in acute and chronic viral hepatitis. , 1986, Progress in liver diseases.

[15]  A. Lok,et al.  Interferon therapy of chronic hepatitis B virus infection in Chinese. , 1986, Journal of hepatology.

[16]  A. Dibisceglie,et al.  Recombinant leukocyte interferon treatment of chronic hepatitis B , 1985, Hepatology.

[17]  J. Chaput,et al.  Lack of in vivo activation of the interferon system in HBsAg‐positive chronic active hepatitis , 1985, Hepatology.

[18]  A. Lok,et al.  Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. , 1985, Journal of hepatology.

[19]  S. Sherlock,et al.  Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. , 2008, Liver.

[20]  T. Merigan,et al.  Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection. , 1983, The Journal of infectious diseases.

[21]  Kenichi Kobayashi,et al.  Interferon production by peripheral lymphocytes in HBsAg‐positive liver diseases , 1982, Hepatology.

[22]  T. Merigan,et al.  Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. , 1981, The Journal of infectious diseases.

[23]  William E. Stewart,et al.  The Interferon System , 1979, Springer Vienna.

[24]  K. Cantell,et al.  Effects of human leucocyte interferon on hepatitis B virus replication and immune responses in patients with chronic hepatitis B infection. , 1979, Journal of clinical & laboratory immunology.

[25]  T. Merigan,et al.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. , 1976, The New England journal of medicine.